On June 20th, Nanolive has launched another ground-breaking tool in cell analysis: the LIVE Cytotoxicity Assay, an AI-powered digital assay with fluorescent labelling that monitors the responses of different cell lines in co-culture simultaneously.
For this event, we had the participation of several key opinion leaders from various pharmaceutical companies and institutions.
Watch the video below, where they share their thoughts on Nanolive’s technology.
Read our latest news
Newsletter June: From live cells to insights: Streamline immunotherapy discovery without labels
Welcome to the June edition of the AI for Live Cell Insights Newsletter, bringing you to the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...
Nanolive releases the next-gen immune profiling solution, the LTCA
Nanolive has released it’s next generation immunotherapy solution: the LIVE T Cell Assay. This real-time digital assay combines label-free live cell imaging and AI-powered analysis to deliver continuous, multiparametric data - ranging from T cell activation to target...
Newsletter May: From live cells to insights: Explore AI-Powered Immune Profiling
Welcome to the May edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live cell...